A nomogram to predict the risk of unfavourable outcome in COVID-19: a retrospective cohort of 279 hospitalized patients in Paris area
暂无分享,去创建一个
V. Vilgrain | B. Fantin | V. Rebours | Jules Grégory | T. Gauss | E. Weiss | F. Bert | A. Galy | K. Peoc’h | S. Curac | J. Moyer | Y. Nguyen | V. Zarrouk | Vasco Honsel | Catherine Paugam Burtz | Catherine Trichet | Felix Corre
[1] Y. Hu,et al. [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.
[2] C. Ferri,et al. COVID-19 and cardiovascular diseases , 2020, Journal of Cardiology.
[3] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[4] Bernard Harmegnies,et al. Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019 , 2020, Journal of internal medicine.
[5] F. Rieux-Laucat,et al. Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients , 2020, medRxiv.
[6] J. Changeux,et al. A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications. , 2020, Comptes rendus biologies.
[7] Nathaniel Hupert,et al. Clinical Characteristics of Covid-19 in New York City , 2020, The New England journal of medicine.
[8] F. Cheng,et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China , 2020, Clinical Microbiology and Infection.
[9] W. Liang,et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China , 2020, Chest.
[10] Jing Xu,et al. Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] A. Chen,et al. Clinical Characteristics of Covid-19 in China. , 2020, The New England journal of medicine.
[12] Mandeep R. Mehra,et al. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.
[13] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[14] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[15] P. Mehta,et al. COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.
[16] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[17] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[18] Chuan Qin,et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[20] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[21] Stef van Buuren,et al. MICE: Multivariate Imputation by Chained Equations in R , 2011 .
[22] Peter C Austin,et al. Bootstrap Methods for Developing Predictive Models , 2004 .
[23] Frank E. Harrell,et al. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .
[24] Daishi Tian,et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China , 2020 .
[25] E. Steyerberg,et al. Focus on : Contemporary Methods in Biostatistics ( I ) Regression Modeling Strategies , 2017 .